| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Dec 31, 2024 | Buy(P) | 5K | $1.21 | $6K | 143K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-000031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Prelude Therapeutics Inc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.